로딩 중…
지수 로딩 중…
프레스티지바이오로직스
334970· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩1,800-2.44%
2026-06-19
Price Chart
프레스티지바이오로직스-50.28%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 139.95B KRW |
| Revenue | 12.53B KRW |
| Net Income | -27.47B KRW |
| Total Assets | 270.29B KRW |
| Net Assets | 135.20B KRW |
| Employees | 211 |
| Value | |
| P/B | 1.04x |
| P/S | 11.17x |
| FCF Yield | -16.82% |
| Profitability | |
| ROE | -20.32% |
| ROA | -10.16% |
| Op. Margin | -268.74% |
| Revenue Growth | 477.83% |
| Financial Health | |
| Debt Ratio | 199.91% |
| Total Debt | 124.12B KRW |
| FCF | -23.53B KRW |
| Cash | 1.58B KRW |
| Current Ratio | 0.40x |
| Performance | |
| 1Y Return | -50.28% |
| 1M Return | -8.91% |
| From 52W High | -65.52% |
| 1Y MDD | -64.30% |
| Trading | |
| Volume | 153,869 shares |
| Foreign Own. | 41.61% |
| Per Share | |
| EPS | -456 KRW |
| BPS | 1,384 KRW |
Company Info
Prestige Biologics, established in 2015 and listed on KOSDAQ in 2021, specializes as a contract manufacturing organization for biopharmaceuticals. The company conducts CDEMO business, providing customized contract manufacturing services for advanced biopharmaceuticals with a 6,000L production facility at its first plant. Its second campus features the ALITA platform, integrating a Smart Factory platform with diverse production methods to enable versatile product manufacturing. Prestige Biologics is headquartered in Cheongju-si, Chungcheongbuk-do.